SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-18-003916
Filing Date
2018-04-13
Accepted
2018-04-13 16:01:57
Documents
3
Period of Report
2018-04-13
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT mbvx8kapr2018.htm 8-K 36022
2 PRESS RELEASE ex99-1.htm EX-99.1 10683
3 IMAGE ex99-1000.jpg GRAPHIC 4551
  Complete submission text file 0001654954-18-003916.txt   54443
Mailing Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121
Business Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001109196 (see all company filings)

IRS No.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37861 | Film No.: 18754338
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1